Found 10 matching trials
Tariquidar-ondansetron Combination in Neuropathic Pain PHASE1 Prospective, randomized, double-blind, placebo controlled, cross-over proof...
Show More Location
Washington University School of Medicine/Barnes-Jewish Hospital
Learn More & Join Trial
PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy PHASE2 Background:
* Tc-94m sestamibi is a radioactive imaging drug approved by t...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) PHASE3 To determine whether tariquidar + first-line single agent vinorelbine chemo...
Show More Location
Multiple Locations
Learn More & Join Trial
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) PHASE3 To determine whether tariquidar + combined first-line chemotherapy of pacli...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors PHASE1 This study will evaluate the tolerance and effects of tariquidar, given in ...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Vinorelbine and XR9576 to Treat Cancer PHASE1 Tumor resistance to anti-cancer drugs is a major problem in cancer treatmen...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer PHASE2 This study will examine the safety and effectiveness of treating adrenocort...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Pgp Transporter and CNS Biodistribution of Ondansetron in Healthy Volunteers PHASE1 To determine the time-course of plasma and CSF concentrations of intravenou...
Show More Location
Washington University in St. Louis
Learn More & Join Trial
Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer PHASE2 The primary objective of this phase II study is to assess if XR9576, a sele...
Show More Location
Florida Oncology Associates
Learn More & Join Trial
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer PHASE2 The purpose of this study is three-fold: 1) to examine the ability of the e...
Show More Location
National Institutes of Health
Learn More & Join Trial